Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3 publications
Therapeutic dosing and targeting efficacy of Pt-Mal-LHRH towards triple negative breast cancer.
Journal: PloS one
Published: December 31, 2022
Pt-Mal-LHRH, a Newly Synthesized Compound Attenuating Breast Cancer Tumor Growth and Metastasis by Targeting Overexpression of the LHRH Receptor.
Journal: Bioconjugate chemistry
Published: December 21, 2016
Showing 1-3 of 3
Last Updated: 09/26/2026